Evidence map›Paper›PMID 40546643›Full record

ArticleCureus2025

Dyspnea and Deception: Overcoming Diagnostic Hurdles in Pulmonary Alveolar Proteinosis.

Ketan Jolly, Merry Mathew, Hanieh Tabatabaei, Barath Rangaswamy

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ketan JollyDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Odessa, USA.
Merry MathewDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Odessa, USA.
Hanieh TabatabaeiDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Odessa, USA.
Barath RangaswamyDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Odessa, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder characterized by abnormal surfactant accumulation due to defective alveolar macrophage clearance. It often presents with exertional dyspnea and nonspecific imaging findings, commonly leading to diagnostic delays. We present the case of a 56-year-old woman with progressive hypoxia initially misattributed to acute respiratory distress syndrome, noncardiogenic pulmonary edema, and hypersensitivity pneumonitis. Corticosteroids were initiated based on early differential considerations. Further evaluation revealed concurrent methicillin-resistant

Indexed as

autoimmune pulmonary alveolar proteinosisbronchoalveolar lavagecrazy paving patterngranulocyte macrophage colony stimulating factorhypoxemic respiratory failuremethicillin-resistant staphylococcus aureussecondary pulmonary infectiontransbronchial lung biopsywhole-lung lavage

Identifiers

PMID40546643
PMCPMC12180566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.